STRO: Sutro Bio Net earnings per share (EPS TTM)

Sutro Biopharma (STRO) - corporate logo

Sutro Biopharma, Inc. (STRO) is gradually depleting its existing capital to fund costly clinical trials. This rolling 12-month EPS chart illustrates the current trend, with the metric currently at -17.58. Strategic alliances with pharma behemoths provide cash inflows, stabilizing free cash flow. However, uncertainty regarding trial outcomes and the high capital intensity of development create certain financial risks.

STRO Sutro Biopharma, Inc. Net earnings per share for the last 12 months (07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for Sutro Biopharma Inc. (STRO)

- share price and expert price forecast:
Stock Quotes Sutro Biopharma, Inc.|STRO - Fair Value Consensus
- market capitalization information:
Market Capitalization Sutro Biopharma, Inc.|STRO - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Sutro Biopharma|STRO - Company Net Assets|Market Value to Book Value Ratio sutrobio.com|STRO - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Sutro Biopharma, Inc.|STRO - Long-Term Debt to Capital|Short-Term Debt to Equity Sutro Bio|STRO - Company Aggregate Debt|Debt to Book Capitalization Ratio Sutro Biopharma, Inc.|STRO - Long-Term Debt|Company Current Liabilities Sutro Biopharma|Quick Liquidity Indicator sutrobio.com
- earnings and multiples data:
STRO - Profit After Payment of Taxes|Projected Future Earnings Sutro Biopharma, Inc.|STRO - Company Value to Net Income|Forward P/E Multiple Sutro Biopharma|STRO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sutro Biopharma, Inc.|STRO - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Sutro Biopharma|STRO - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months sutrobio.com|STRO - Earnings per share trend in current year|Expected earnings per share growth for next year Sutro Biopharma, Inc.
Fundamental valuation:STRO - Sutro Biopharma, Inc.
Flagship merchandise of Sutro Bio

The calculation model for this indicator is highly sensitive to operational efficiency and actual business profitability. This metric determines the portion of net income attributable to a single common share over a rolling year. For Sutro Biopharma, Inc. (STRO), which develops high-precision oncotherapeutic conjugates, this serves as an indicator of the monetization of its scientific research. Analyzing the per-share profit trend over the last 12 months allows for the separation of speculative noise from fundamental performance.

Main competitors

IBRX: Net earnings per share for the last 12 months|Earnings per share for the trailing year IMCR (immunocore.com)|JANX: Net earnings per share (EPS TTM)|RCUS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Zymeworks Corp|Net earnings per share for the last 12 months Tango Therapeutics Corp (TNGX)|Earnings per share for the last twelve months Iovance Biotherapeutics (IOVA)|Net earnings per share for the last 12 months immatics.com IMTX|Xencor - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Compass Therapeutics Inc CMPX|REPL - Earnings per share for the last twelve months|LYEL (Lyell Pharma) - Earnings per share for the last 12 months|Innate Pharma S.A. (IPHA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Pyxis Oncology (PYXS)|Net earnings per share for the last 12 months CGEN|IOBT - Net earnings per share for the trailing year|Net earnings per share for the last 12 months INKT (MiNK)|Earnings per share for the last four quarters HOWL|Net earnings per share (EPS TTM) IMMX (Immix Biopharma)|Earnings per share for the trailing year ALXO|Cue Biopharma, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months PDS Biotechnology|sonnetbio.com (SONN) - Earnings per share for the last twelve months|MAIA Bio - Earnings per share for the trailing year|LIMN (Liminatus Pharma) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Lava Tx|Earnings per share for the last twelve months NextCure (NXTC)|LPTX: Earnings per one share for the last 12 months|Intensity Therapeutics, Inc. - Net earnings per share for the last 12 months|Sensei Biotherapeutics Inc (SNSE) - Net earnings per one share for the last twelve months|TOVX - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Gritstone bio, Inc. GRTS|KA (Kineta) - Net earnings per share for the last 12 months|NexImmune Inc (NEXI) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months TSBX|VCNX (Vaccinex Inc) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Harpoon Therapeutics (HARP)